Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FDG-PET/CT as a Method of Patient Selection and Response Evaluation in Patients With Peritoneal Metastasis Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy. A Pilot Study

NCT06144853 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT06144853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06144853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FDG-PET/CT as a Method of Patient Selection and Response Evaluation in Patients With Peritoneal Metastasis Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy. A Pilot Study
Lead sponsor
Odense University Hospital
Phase
Observational
Overall status
Completed
Start date
March 15, 2024
Completion date
March 5, 2026
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal cancer, peritoneal cancer, peritoneal carcinomatosis, peritoneal metastases